X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5915) 5915
Book Chapter (61) 61
Dissertation (12) 12
Magazine Article (9) 9
Conference Proceeding (4) 4
Web Resource (3) 3
Book / eBook (2) 2
Government Document (2) 2
Paper (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3920) 3920
diabetes mellitus, type 2 - drug therapy (2192) 2192
male (2001) 2001
animals (1903) 1903
dipeptidyl-peptidase iv inhibitors - therapeutic use (1890) 1890
female (1514) 1514
hypoglycemic agents - therapeutic use (1330) 1330
type 2 diabetes (1277) 1277
endocrinology & metabolism (1194) 1194
middle aged (1120) 1120
diabetes (1098) 1098
dipeptidyl-peptidase iv inhibitors - pharmacology (1058) 1058
glucagon-like peptide-1 (1001) 1001
pharmacology & pharmacy (949) 949
dipeptidyl peptidase 4 - metabolism (936) 936
dipeptidyl peptidase-iv (903) 903
aged (894) 894
dipeptidyl peptidase iv (876) 876
sitagliptin (791) 791
dipeptidyl-peptidase iv inhibitors - adverse effects (788) 788
rats (714) 714
dipeptidyl-peptidase-iv (695) 695
adult (688) 688
mice (667) 667
glucose (656) 656
treatment outcome (650) 650
adamantane - analogs & derivatives (645) 645
biochemistry & molecular biology (634) 634
diabetes mellitus, type 2 - blood (618) 618
dipeptidyl-peptidase iv inhibitors - administration & dosage (582) 582
hypoglycemic agents - adverse effects (574) 574
metformin (547) 547
diabetes mellitus (544) 544
analysis (533) 533
double-blind (530) 530
hypoglycemic agents (525) 525
blood glucose - metabolism (523) 523
insulin (511) 511
sitagliptin phosphate (501) 501
glycemic control (494) 494
drug therapy, combination (483) 483
dipeptidyl peptidase-4 inhibitor (477) 477
hypoglycemic agents - pharmacology (477) 477
blood glucose - drug effects (470) 470
vildagliptin (460) 460
cd26 (437) 437
dipeptidyl-peptidase iv inhibitors (435) 435
care and treatment (433) 433
hypoglycemic agents - administration & dosage (431) 431
risk factors (419) 419
expression (414) 414
research (407) 407
metformin - therapeutic use (375) 375
safety (375) 375
peptidase (374) 374
adamantane - therapeutic use (362) 362
type 2 diabetes mellitus (361) 361
diabetes mellitus, type 2 - complications (358) 358
peptides (353) 353
chemistry, medicinal (349) 349
medicine, general & internal (347) 347
dpp-4 inhibitor (344) 344
type-2 diabetes-mellitus (343) 343
efficacy (335) 335
internal medicine (334) 334
diabetes mellitus, type 2 - metabolism (326) 326
glp-1 (326) 326
glycated hemoglobin a - metabolism (322) 322
drug therapy (320) 320
medicine, research & experimental (320) 320
inhibitors (318) 318
dipeptidyl peptidase-4 inhibitors (313) 313
dextrose (308) 308
diabetes therapy (306) 306
glucagon (306) 306
triazoles - therapeutic use (304) 304
beta-cell function (298) 298
pyrazines - therapeutic use (298) 298
linagliptin (293) 293
dipeptidyl peptidase 4 (286) 286
dipeptidyl-peptidase iv inhibitors - chemistry (284) 284
abridged index medicus (278) 278
double-blind method (277) 277
cell biology (269) 269
time factors (269) 269
health aspects (268) 268
dose-response relationship, drug (264) 264
proteins (262) 262
therapy (262) 262
cardiac & cardiovascular systems (260) 260
insulin resistance (258) 258
inflammation (255) 255
hyperglycemia (253) 253
risk (252) 252
clinical trials (251) 251
pyrrolidines - therapeutic use (251) 251
sulfonylurea compounds - therapeutic use (250) 250
dipeptidyl-peptidase iv inhibitors - pharmacokinetics (249) 249
dipeptidyl peptidase 4 - chemistry (246) 246
dpp-4 inhibitors (246) 246
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5774) 5774
Japanese (95) 95
German (51) 51
French (43) 43
Spanish (32) 32
Chinese (22) 22
Korean (22) 22
Russian (16) 16
Hungarian (13) 13
Czech (12) 12
Portuguese (11) 11
Italian (7) 7
Polish (7) 7
Croatian (4) 4
Danish (3) 3
Dutch (3) 3
Turkish (2) 2
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of medicinal chemistry, ISSN 0022-2623, 04/2014, Volume 57, Issue 8, pp. 3205 - 3212
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 14, pp. 1317 - 1326
Saxagliptin, a new oral antihyperglycemic drug in the DPP-4 inhibitor class, had no effect on the risk of cardiovascular events in patients with type 2... 
no | ALL-CAUSE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EVENTS | GLUCOSE CONTROL | MICROALBUMINURIA | DISEASE | CLINICAL-USE | PREVENTION | RISK | DEATH | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Adamantane - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Hypoglycemia - chemically induced | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Adamantane - adverse effects | Adamantane - analogs & derivatives | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Dipeptides - therapeutic use | Double-Blind Method | Pancreatitis - epidemiology | Dipeptides - adverse effects | Kaplan-Meier Estimate | Pancreatitis - chemically induced | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Patient outcomes | Dosage and administration | Drug therapy | Heart diseases | Risk factors | Saxagliptin | Myocardial infarction | Cerebral infarction | Heart attacks | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Patients | Heart rate | Ischemia | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent)
Journal Article
Journal Article
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 10/2015, Volume 42, Issue 10, pp. 999 - 1024
Journal Article